Synopsys 8-K
PositiveEarningsGuidance raised
AI-driven demand underpins raised FY2026 targets; EDA and Ansys lead strength as Design IP returns to Y/Y growth.
Filed 2026-08-26 16:21 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q3 FY2026 results with Q4 and full-year guidance. Revenue was $2.48B, up 42.4% Y/Y, with GAAP diluted EPS of $2.84 and non-GAAP diluted EPS of $3.91. Synopsys raised FY2026 revenue, non-GAAP operating margin, non-GAAP EPS and cash-flow guidance, citing continued AI-driven demand and expected double-digit growth in Design Automation.
Key Figures
| Metric | Q3 2026 | Q3 2025 | Y/Y |
|---|---|---|---|
| Revenue | $2.48B | $1.74B | 42.4% |
| Operating income, GAAP | $357M | $165M | 116% |
| Net income from continuing operations attributable to Synopsys, GAAP | $546M | $243M | 125% |
| Net income from continuing operations attributable to Synopsys, non-GAAP | $753M | $549M | 37.1% |
| Diluted EPS, GAAP | $2.84 | $1.50 | 89.3% |
| Diluted EPS, non-GAAP | $3.91 | $3.39 | 15.3% |
- Segment revenue: Design Automation $2.00B (+52.7% Y/Y) and Design IP $474M (+10.8%). Synopsys cited broad-based strength led by EDA, a strong Ansys quarter and a return to Y/Y growth in Design IP.
- 9M operating cash flow was $2.30B vs $879M; FCF was $2.14B vs $744M, calculated as operating cash flow less capital expenditures.
- At 7/31/2026, cash, cash equivalents and short-term investments were $3.61B and debt carrying value was $10.0B, down from $13.5B at 10/31/2025. 9M debt repayments were $3.46B; financing also included a $2.0B common-stock private placement and $300M of treasury-stock purchases. Period-end shares outstanding increased 3.0%, to 191.6M from 186.0M.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Revenue | Q4 FY2026 | $2.530B-$2.580B | — | — |
| Revenue | FY2026 | $9.690B-$9.740B | — | Raised |
| GAAP expenses | Q4 FY2026 | $2.225B-$2.300B | — | — |
| GAAP expenses | FY2026 | $8.667091B-$8.742091B | — | — |
| Non-GAAP expenses | Q4 FY2026 | $1.450B-$1.480B | — | — |
| Non-GAAP expenses | FY2026 | $5.67B-$5.7B | — | — |
| Non-GAAP interest and other income (expense), net | Q4 FY2026 | $(119)M-$(115)M | — | — |
| Non-GAAP interest and other income (expense), net | FY2026 | $(485)M-$(481)M | — | — |
| Non-GAAP tax rate | Q4 FY2026 | 18% | — | — |
| Non-GAAP tax rate | FY2026 | 18% | — | — |
| Fully diluted shares outstanding | Q4 FY2026 | 192M-194M | — | — |
| Fully diluted shares outstanding | FY2026 | 192M-194M | — | — |
| GAAP operating margin | FY2026 | ≈10.4% midpoint | — | — |
| Non-GAAP operating margin | FY2026 | ≈41.5% midpoint | — | Raised |
| GAAP EPS | Q4 FY2026 | $0.60-$0.85 | — | — |
| GAAP EPS | FY2026 | $3.84-$4.08 | — | — |
| Non-GAAP EPS | Q4 FY2026 | $4.10-$4.16 | — | — |
| Non-GAAP EPS | FY2026 | $15.04-$15.10 | — | Raised |
| Operating cash flow | FY2026 | ≈$2.8B | — | Raised |
| FCF | FY2026 | ≈$2.6B | — | Raised |
| Capital expenditures | FY2026 | ≈$225M | — | — |
The targets assume no further changes to export-control restrictions or current U.S. Entity List restrictions.
Investor Takeaways
- Q4 revenue and EPS against the guided ranges will test whether the reported momentum continues; FY2026 results will show whether the raised full-year targets are achieved.
- Watch for changes in export-control restrictions, which the FY2026 targets assume remain unchanged.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3